Press Releases - Haleon
WEBGender pay gap. Diversity, equity & inclusion. Human Rights. Being a responsible business is one of Haleon's four strategic priorities. See how we performed in 2022. ESG Reporting Hub. Investors. 100% Pure-play consumer health company with a clear purpose to deliver better everyday health with humanity.
Sensodyne-maker Haleon jumps on share buyback, falling debt
WEBFeb 29 (Reuters) - Haleon (HLN.L) plans to buy back 500 million pounds ($633 million) of its shares this year amid firm demand for its products and progress in reducing debt, sending the British...
Haleon Announces Leadership Transition in Canada: Rupa Bahri to …
WEBOct 1, 2024 · Haleon, a global leader in consumer health, today announced the appointment of Christine Jakovcic as General Manager, Haleon Canada. This appointment follows Rupa Bahri stepping down after a ...
Haleon launches with purpose to deliver better everyday health …
WEBHaleon launches as an independent consumer health company, completing its GSK demerger. Trading commenced on the LSE with the CEO leading the ceremony. NYSE trading and a market-opening event are set for July 20, 2022.
GSK announces independent Consumer Healthcare company is to …
WEBFeb 22, 2022 · Haleon will be a new world-leader in consumer health with an exceptional portfolio of category-leading brands, including Sensodyne, Voltaren, Panadol and Centrum. Business is on track to demerge and list as a new company in mid-2022.
Haleon reports strong revenue growth in first results since GSK split
WEBSep 20, 2022 · Healthcare company Haleon has reported a double-digit hike in revenue and profits in the group’s first set of company results since it spun off from pharma giant GSK.
Haleon launches with purpose to deliver better everyday health …
WEBWARREN, N.J., July 18, 2022 /PRNewswire/ -- Today, Haleon (LSE/NYSE: HLN) launches as an independent company 100% focused on consumer health, completing its demerger from GSK. The newly listed...
Drug giant Pfizer sells $3.3 bln stake in Sensodyne-maker Haleon
WEBSep 30, 2024 · Pfizer to remain top Haleon shareholder -LSEG data. Oct 1 (Reuters) - Pfizer (PFE.N) sold a stake in British consumer healthcare group Haleon (HLN.L) worth about $3.26 billion on Monday, cutting ...
Haleon not surprised by Pfizer stake sale plans, says CFO
WEBMay 3, 2023 · Pfizer's plan to sell its Haleon stake is not a surprise, the consumer health company's finance chief Tobias Hestler told Reuters on Wednesday.
Haleon can shine as investors seek safety in consumer healthcare
WEBAug 5, 2024 · The resilience of brands such as Advil, Sensodyne and Panadol is fuelling investors’ interest in London-listed Haleon — as are fears about the US economy and overvalued technology stocks.